Survival in people with type 2 diabetes as a function of HbA1c

The Lancet

Volumn 375, Issue 9713, 2010, Pages 438-440

  Balkau, Beverley ^a,b   Simon, Dominique ^a,c  

^a CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; INSULIN SENSITIZING AGENT; METFORMIN; SULFONYLUREA;

ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; DIABETIC PATIENT; DOSE RESPONSE; HEART INFARCTION; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; LIFESPAN; MICROANGIOPATHY; MONOTHERAPY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL;

EID: 75949107385     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)62192-9     Document Type: Note

References (13)

1. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358 (2008) 2545-2559
2. The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358 (2008) 2560-2572
3. Duckworth W., Abraira C., Moritz T., et al., for the VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360 (2009) 129-139
4. Ray K.K., Seshasai S.R.K., Wijesuriya S., et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 373 (2009) 1765-1772
5. Turnbull F.M., Abraira C., Anderson R.J., et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 52 (2009) 2288-2298
6. Mannucci E., Monami M., Lamanna C., et al. Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis 19 (2009) 604-612
7. Holman R.R., Paul S.K., Bethel M.A., et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359 (2008) 1577-1589
8. 1c in people with type 2 diabetes: a retrospective cohort study. Lancet (2010) 10.1016/S0140-6736(09)61969-3 published online Jan 27.
9. Miller C.D., Phillips L.S., Ziemer D.C., et al. Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med 161 (2001) 1653-1659
10. Tzoulaki I., Molokhia M., Curcin V., et al. Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database. BMJ 339 (2009) b4731
11. Gamble J.M., Simpson S.H., Eurich D.T., Majumdar S.R., and Johnson J.A. Insulin use and increased risk of mortality in type 2 diabetes: a cohort study. Diabetes Obes Metab (2009) 10.1111/j.1463-1326.2009.01125.x published online Sept 24.
12. Amiel S.A., Dixon T., Mann R., and Jameson K. Hypoglycaemia in type 2 diabetes. Diabet Med 25 (2008) 245-254
13. Amiel S.A. Hypoglycemia: from the laboratory to the clinic. Diabetes Care 32 (2009) 1364-1371